U.S. In-vitro Toxicology Testing Market Size & Outlook
U.S. in-vitro toxicology testing market, 2018-2030 (US$M)
Related Markets
U.S. in-vitro toxicology testing market highlights
- The U.S. in-vitro toxicology testing market generated a revenue of USD 13,673.1 million in 2023 and is expected to reach USD 29,568.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.6% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
In-vitro toxicology testing market data book summary
| Market revenue in 2023 | USD 13,673.1 million |
| Market revenue in 2030 | USD 29,568.2 million |
| Growth rate | 11.6% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 44.1% of the global in-vitro toxicology testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. in-vitro toxicology testing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,697.2 million by 2030.
Pharmaceutical industry was the largest segment with a revenue share of 43.25% in 2023. Horizon Databook has segmented the U.S. in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Competition in the in-vitro toxicology testing market is intense, as companies strive to offer high-quality, cost-effective testing services that meet the needs of their customers. The market is driven by factors such as increased regulatory scrutiny and the growing demand for alternative testing methods. For instance, the FDA Modernization Act 2.0 was unanimously passed by both the U.S.
Researchers and companies are increasingly relying on nonanimal testing methods, such as organ-on-achip technologies, in vitro cell-based assays, and computer modeling, to investigate the mechanisms of diseases and test the efficacy of new drugs.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Testing Market Scope
In-vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. in-vitro toxicology testing market size, by end user, 2018-2030 (US$M)
U.S. In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
